A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2002
11/14/2002	US20020169149 Antimicrobial formulations
11/14/2002	US20020169145 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
11/14/2002	US20020169144 Angiogenesis inhibition
11/14/2002	US20020169142 Viscoelastics for use in middle ear surgery
11/14/2002	US20020169140 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections
11/14/2002	US20020169138 Delivery vehicles for bioactive agents and uses thereof
11/14/2002	US20020169130 Medical device and methods of use for glaucoma treatment
11/14/2002	US20020169114 Formulation of boronic acid compounds
11/14/2002	US20020169102 Intranasal delivery of agents for regulating development of implanted cells in the CNS
11/14/2002	US20020168522 Nanotechnology for electronic and opto-electronic devices
11/14/2002	US20020168434 Cyclooxygenase inhibitor; anticancer agents, Alzheimer's disease, central nervous system disorders
11/14/2002	US20020168427 Plant extract
11/14/2002	US20020168426 Viricides, bactericides
11/14/2002	US20020168424 Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
11/14/2002	US20020168415 Biocompatible; culture product; anticancer agents
11/14/2002	US20020168414 Rapid dehydration of proteins
11/14/2002	US20020168413 Microstructure grains; fine particle size
11/14/2002	US20020168412 Topical drug preparations
11/14/2002	US20020168411 Spill resistant pharmaceutical system
11/14/2002	US20020168410 Modulated release from biocompatible polymers
11/14/2002	US20020168409 Drug binded to polysaccharide, dextran; sustained release
11/14/2002	US20020168408 Synthetic particulate vectors and preparation process
11/14/2002	US20020168407 Process for preparing low-viscosity, aqueous cellulose ether solutions
11/14/2002	US20020168406 Gel overcoated with polylysine
11/14/2002	US20020168405 Novel Method of treatment
11/14/2002	US20020168404 Use of an acrylic type polymer as disintegrating agent
11/14/2002	US20020168403 Mixture of monoamine oxidase inhibitor and additive substance; reducing withdrawal
11/14/2002	US20020168402 Microprecipitation method for preparing submicron suspensions
11/14/2002	US20020168401 Packaging system for transdermal drug delivery systems
11/14/2002	US20020168399 Applicator and method for applying lanolin to a sore nipple
11/14/2002	US20020168397 Antiallergens, antiinflammatory agents; oral administering
11/14/2002	US20020168396 In situ administering; sustained release
11/14/2002	US20020168395 Uniform crystal structure
11/14/2002	US20020168389 Oil in water emulsion; skin disorders
11/14/2002	US20020168387 Bactericidal gel and method for treating burns and dermal lesions
11/14/2002	US20020168386 Instant granules and process for their formulation
11/14/2002	US20020168355 Cationic liposome delivery of taxanes to angiogenic blood vessels
11/14/2002	US20020168337 Sustained-release preparation
11/14/2002	US20020168336 Orthopedic implants or vehicles for sustained delivery of pharmaceutical, cosmetic and agricultural agents
11/14/2002	US20020168334 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
11/14/2002	US20020168323 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/14/2002	US20020168322 For delivering an active agent formulation to the lung of a human
11/14/2002	US20020168319 For providing local radiotherapy for therapy of tumor and arterio-venous malformations in a blood vessel
11/14/2002	DE10213304A1 Topical pharmaceutical composition having carrier system forming lamellar double membrane structure with water, providing good skin barrier permeation and high bioavailability without side-effects
11/14/2002	DE10122898A1 Use of 2-phenyl-4-chromanone derivatives to mask bitter or metallic tastes in foods, consumables and oral pharmaceutical products
11/14/2002	DE10122855A1 Medicament composition containing oligoglycerol mono-ether derivative, as tissue membrane and organ barrier penetration improving agent to increase effectiveness of an active agent
11/14/2002	DE10122786A1 Stable, film-forming aqueous polyvinyl acetate emulsion, obtained by radical polymerization in presence of regulator, useful e.g. for producing sprayable plasters or release-controlling coatings on drugs or agrochemicals
11/14/2002	DE10121982A1 Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung Nanoparticles of protein with coupled apolipoprotein E to cross the blood-brain barrier and method for their preparation
11/14/2002	CA2827671A1 Phosphorus-containing antimicrobial compounds and methods for their use
11/14/2002	CA2446946A1 Gene transfer of angiogenic factor for skin disease
11/14/2002	CA2446528A1 Disinfecting and solubilizing steroid compositions
11/14/2002	CA2446060A1 Compositions and delivery systems for administration of a local anesthetic agent
11/14/2002	CA2445944A1 Method of preventing type 2 diabetes with aerosolized insulin
11/14/2002	CA2445933A1 Gelatin substitute
11/14/2002	CA2445381A1 Phosphorous containing antimicrobial compounds and methods for their use
11/14/2002	CA2445146A1 Formation of small crystals
11/14/2002	CA2444718A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
11/14/2002	CA2444013A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/14/2002	CA2442969A1 Methods for selective immunomodulation using pimecrolimus
11/13/2002	EP1256346A1 Remedies for external use for allergic skin diseases
11/13/2002	EP1256340A1 Improved transdermal therapeutic system for the treatment of Parkinson's disease
11/13/2002	EP1256339A1 Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
11/13/2002	EP1256338A2 A process for the preparation of direct tabletting formulations and aids
11/13/2002	EP1256337A1 Method and compositions for applying an agent to a substrate
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255828A2 Small oligonucleotides with anti-tumor activity
11/13/2002	EP1255827A2 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/13/2002	EP1255823A1 Slow release protein polymers
11/13/2002	EP1255793A1 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate
11/13/2002	EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002	EP1255725A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
11/13/2002	EP1255578A1 Array and method for dosing a hormone regulating blood sugar in a patient
11/13/2002	EP1255576A1 Mineral-polymer hybrid composition
11/13/2002	EP1255566A2 Preparation of aqueous clear solution dosage forms with bile acids
11/13/2002	EP1255565A1 Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
11/13/2002	EP1255563A1 Composition of antigen and glycolipid adjuvant sublingual administration
11/13/2002	EP1255561A2 Proteosome influenza vaccine
11/13/2002	EP1255557A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation
11/13/2002	EP1255552A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/13/2002	EP1255551A1 Use of paullone derivatives for making medicines
11/13/2002	EP1255549A1 Water dispersible formulation of paroxetine
11/13/2002	EP1255547A1 Controlled-release compositions containing opioid agonist and antagonist
11/13/2002	EP1255544A1 Mucin synthesis inhibitors
11/13/2002	EP1255540A1 Ophthalmic use of alpha adrenergic blocking agents
11/13/2002	EP1255535A2 Controlled release pharmaceutical composition containing tramadol hydrochloride
11/13/2002	EP1255534A2 Method for the preparation of microspheres which contain colloidal systems
11/13/2002	EP1255533A2 Magnetoliposome composition for targeted treatment of biological tissue
11/13/2002	EP1255532A1 Osmotically-driven fluid dispenser and coating composition
11/13/2002	EP1255529A2 Oil-free cosmetic or dermatological preparations containing solid and liquid uv filter substances
11/13/2002	EP1255519A2 Multi-purpose drug and heat therapy treatment system
11/13/2002	EP1255447A2 Biopolymer thickener
11/13/2002	EP1150738B1 Implant
11/13/2002	EP0991407B9 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
11/13/2002	EP0952851A4 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
11/13/2002	EP0912167B1 Granulates of hexahydropyrazine derivatives which can be administered orally
11/13/2002	EP0892638B1 Liposome-based topical vitamin d formulation
11/13/2002	EP0874765B1 Improved storage wrap material
11/13/2002	EP0841896B1 Reverse gels comprising a continuous fluorinated phase
11/13/2002	EP0814777B1 Stable lipid-comprising drug delivery complexes and methods for their production
11/13/2002	EP0814753B1 Cosmetic or dermatological gels based on microemulsions

1 ... 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 ... 2991